NCT03442751Phase 3Completed

Study to Evaluate the Safety and Efficacy of Epi-on Corneal Cross-linking in Eyes With Progressive Keratoconus

Study sponsor: Glaukos Corporation

Primary completion is the date data collection ends for the main study measures, not when results are published.

Primary completion2019-11-01Actual
Enrollment · participants201Actual
Source updated2024-01-30Last update listed in the registry record

Changes to this trial

Last 12 months
Filters
Clear filters
No recorded changes are available for this view and time period. Our history may be incomplete; this does not establish that the trial stayed unchanged.

Explore older trial changes

Upgrade to Pro to see the full available history for this trial.

Upgrade to Pro Illustrative preview